Comparator & Reference Listed Drug (RLD) Sourcing for Regulated Development

Structured sourcing of SRA-origin RLDs and comparator products for bioequivalence (BE) and ANDA pathways.

SRA-Origin Market Coverage

FDA
United States
MHRA
United Kingdom
EMA
European Union
Health Canada
Canada
TGA
Australia
Medsafe
New Zealand
PMDA
Japan

Origin market visibility confirmed at quotation stage.

Comparator & RLD scope

What We Source

  • FDA-designated Reference Listed Drugs (RLDs)
  • Comparator products for BE and analytical studies
  • Representative commercial batches (where available)
  • Hard-to-source and limited-availability products

Development-Aware Sourcing Approach

  • Target submission market
  • Reference product designation
  • Batch suitability and expiry window
  • Storage condition requirements

Role clarity

Imperial Co operates as a sourcing and logistics partner. We do not provide regulatory consulting, filing advice, or guarantees of regulatory acceptance. All products are supplied for regulated development and study use in accordance with client-defined requirements.

Next steps

Search our database or submit a custom sourcing request for your specific requirements.

Request a Quote Search 1000+ Products

How it works

  1. Step 1 Share molecule, target submission market, and timeline
  2. Step 2 We confirm RLD alignment, batch availability, and expiry window
  3. Step 3 Receive quotation with sourcing origin and documentation scope
  4. Step 4 Approve procurement and shipping conditions
  5. Step 5 Receive product with shipment records and traceability documentation

Read our full process